Innovations in Gene Delivery Platform Technology

Share this:
     
Published: 13 Apr 2018

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across gene delivery platform technologies. Since immuno-oncology and rare diseases are the most focused therapeutic areas in recent times, the TOE highlights recent innovations in these fields. The corresponding clinical trials scenario is also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Gene delivery platform technology, genetically modified probiotic bacteria, immuno-oncology, adeno-associated virus gene therapy, non-viral gene delivery, hematopoietic stem cells, anti-tumor proteins

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..